Carey RM, Siragy HM. The intrarenal renin-angiotensin system and diabetic nephropathy. Trends Endocrinol Metab. 2003;14:274–81.
Article
CAS
Google Scholar
Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2022. CA Cancer J Clin. 2022;72:7–33.
Article
Google Scholar
Cancer of the Kidney and Renal Pelvis—Cancer Stat Facts, https://seer.cancer.gov/statfacts/html/kidrp.html . Accessed 26 Nov 2022.
Espana-Agusti J, Warren A, Chew SK, et al. Loss of PBRM1 rescues VHL dependent replication stress to promote renal carcinogenesis. Nat Commun. 2017;8:2026.
Article
Google Scholar
Tan X, Liu Y, Hou J, et al. Targeted therapies for renal cell carcinoma in Chinese patients: focus on everolimus. Onco Targets Ther. 2015;8:313–21.
Google Scholar
Wang X, Yang L, Chen ZG, et al. Application of nanotechnology in cancer therapy and imaging. CA Cancer J Clin. 2008;58:97–110.
Article
Google Scholar
Ljungberg B, Albiges L, Abu-Ghanem Y, et al. European Association of Urology Guidelines on renal cell carcinoma: the 2022 update. Eur Urol. 2022.
Tunio MA, Hashmi A, Rafi M. Need for a new trial to evaluate postoperative radiotherapy in renal cell carcinoma: a meta-analysis of randomized controlled trials. Ann Oncol. 2010;21:1839–45.
Article
CAS
Google Scholar
Redova M, Svoboda M, Slaby O. MicroRNAs and their target gene networks in renal cell carcinoma. Biochem Biophys Res Commun. 2011;405:153–6.
Article
CAS
Google Scholar
Barata PC, Rini BI. Treatment of renal cell carcinoma: current status and future directions. CA Cancer J Clin. 2017;67:507–24.
Article
Google Scholar
Farokhzad OC, Langer R. Impact of nanotechnology on drug delivery. ACS Nano. 2009;3:16–20.
Article
CAS
Google Scholar
Burgess P, Hutt PB, Farokhzad OC, et al. On firm ground: IP protection of therapeutic nanoparticles. Nat Biotechnol. 2010;28:1267–70.
Article
CAS
Google Scholar
Gu Y, Zhong Y, Meng F, et al. Acetal-linked paclitaxel prodrug micellar nanoparticles as a versatile and potent platform for cancer therapy. Biomacromol. 2013;14:2772–80.
Article
CAS
Google Scholar
Nastase MV, Zeng-Brouwers J, Wygrecka M, et al. Targeting renal fibrosis: mechanisms and drug delivery systems. Adv Drug Deliv Rev. 2018;129:295–307.
Article
CAS
Google Scholar
Liu CP, Hu Y, Lin JC, et al. Targeting strategies for drug delivery to the kidney: from renal glomeruli to tubules. Med Res Rev. 2019;39:561–78.
Article
CAS
Google Scholar
Oroojalian F, Charbgoo F, Hashemi M, et al. Recent advances in nanotechnology-based drug delivery systems for the kidney. J Control Release. 2020;321:442–62.
Article
CAS
Google Scholar
Zhang Y, Rana A, Stratton Y, et al. Sequence-specific detection of microRNAs related to clear cell renal cell carcinoma at fM concentration by an electroosmotically driven nanopore-based device. Anal Chem. 2017;89:9201–8.
Article
CAS
Google Scholar
Zheng S, Zhang M, Bai H, et al. Preparation of AS1411 aptamer modified Mn-MoS(2) QDs for targeted MR imaging and fluorescence labelling of renal cell carcinoma. Int J Nanomed. 2019;14:9513–24.
Article
CAS
Google Scholar
Wang Z, An HW, Hou D, et al. Addressable peptide self-assembly on the cancer cell membrane for sensitizing chemotherapy of renal cell carcinoma. Adv Mater. 2019;31: e1807175.
Article
Google Scholar
Pal K, Madamsetty VS, Dutta SK, et al. Co-delivery of everolimus and vinorelbine via a tumor-targeted liposomal formulation inhibits tumor growth and metastasis in RCC. Int J Nanomed. 2019;14:5109–23.
Article
CAS
Google Scholar
Shaw G. The silent disease. Nature. 2016;537:S98–9.
Article
CAS
Google Scholar
Cohen HT, McGovern FJ. Renal-cell carcinoma. N Engl J Med. 2005;353:2477–90.
Article
CAS
Google Scholar
Colaianni L, Kung SC, Taggart DK, et al. Reduction of spectral interferences using ultraclean gold nanowire arrays in the LDI-MS analysis of a model peptide. Anal Bioanal Chem. 2014;406:4571–83.
Article
CAS
Google Scholar
Ocsoy I, Gulbakan B, Shukoor MI, et al. Aptamer-conjugated multifunctional nanoflowers as a platform for targeting, capture, and detection in laser desorption ionization mass spectrometry. ACS Nano. 2013;7:417–27.
Article
CAS
Google Scholar
Zhou K, Zhang Y, Xia Z, et al. As-prepared MoS2 quantum dot as a facile fluorescent probe for long-term tracing of live cells. Nanotechnology. 2016;27: 275101.
Article
Google Scholar
Nizioł J, Ossoliński K, Tripet BP, et al. Nuclear magnetic resonance and surface-assisted laser desorption/ionization mass spectrometry-based serum metabolomics of kidney cancer. Anal Bioanal Chem. 2020;412:5827–41.
Article
Google Scholar
Gupta A, Nath K, Bansal N, et al. Role of metabolomics-derived biomarkers to identify renal cell carcinoma: a comprehensive perspective of the past ten years and advancements. Expert Rev Mol Diagn. 2020;20:5–18.
Article
CAS
Google Scholar
Ganti S, Weiss RH. Urine metabolomics for kidney cancer detection and biomarker discovery. Urol Oncol. 2011;29:551–7.
Article
CAS
Google Scholar
Lin L, Yu Q, Yan X, et al. Direct infusion mass spectrometry or liquid chromatography mass spectrometry for human metabonomics? A serum metabonomic study of kidney cancer. Analyst. 2010;135:2970–8.
Article
CAS
Google Scholar
Kind T, Tolstikov V, Fiehn O, et al. A comprehensive urinary metabolomic approach for identifying kidney cancerr. Anal Biochem. 2007;363:185–95.
Article
CAS
Google Scholar
Kim K, Aronov P, Zakharkin SO, et al. Urine metabolomics analysis for kidney cancer detection and biomarker discovery. Mol Cell Proteomics. 2009;8:558–70.
Article
CAS
Google Scholar
Kim K, Taylor SL, Ganti S, et al. Urine metabolomic analysis identifies potential biomarkers and pathogenic pathways in kidney cancer. OMICS. 2011;15:293–303.
Article
CAS
Google Scholar
Ganti S, Taylor SL, Kim K, et al. Urinary acylcarnitines are altered in human kidney cancer. Int J Cancer. 2012;130:2791–800.
Article
CAS
Google Scholar
Niziol J, Bonifay V, Ossolinski K, et al. Metabolomic study of human tissue and urine in clear cell renal carcinoma by LC-HRMS and PLS-DA. Anal Bioanal Chem. 2018;410:3859–69.
Article
CAS
Google Scholar
Abdelhamid HN, Wu HF. Gold nanoparticles assisted laser desorption/ionization mass spectrometry and applications: from simple molecules to intact cells. Anal Bioanal Chem. 2016;408:4485–502.
Article
CAS
Google Scholar
Niziol J, Ossolinski K, Ossolinski T, et al. Surface-transfer mass spectrometry imaging of renal tissue on gold nanoparticle enhanced target. Anal Chem. 2016;88:7365–71.
Article
CAS
Google Scholar
Arendowski A, OssoliŃski K, Niziol J, et al. Screening of urinary renal cancer metabolic biomarkers with gold nanoparticles-assisted laser desorption/ionization mass spectrometry. Anal Sci. 2020;36:1521–7.
Article
CAS
Google Scholar
Arendowski A, Ossoliński K, Ossolińska A, et al. Serum and urine analysis with gold nanoparticle-assisted laser desorption/ionization mass spectrometry for renal cell carcinoma metabolic biomarkers discovery. Adv Med Sci. 2021;66:326–35.
Article
CAS
Google Scholar
Nizioł J, Ossoliński K, Tripet BP, et al. Nuclear magnetic resonance and surface-assisted laser desorption/ionization mass spectrometry-based metabolome profiling of urine samples from kidney cancer patients. J Pharm Biomed Anal. 2021;193: 113752.
Article
Google Scholar
Nizioł J, Ossoliński K, Ossoliński T, et al. Surface-transfer mass spectrometry imaging of renal tissue on gold nanoparticle enhanced target. Anal Chem. 2016;88:7365–71.
Article
Google Scholar
Arendowski A, Nizioł J, Ossoliński K, et al. Laser desorption/ionization MS imaging of cancer kidney tissue on silver nanoparticle-enhanced target. Bioanalysis. 2018;10:83–94.
Article
CAS
Google Scholar
Nizioł J, Sunner J, Beech I, et al. Localization of metabolites of human kidney tissue with infrared laser-based selected reaction monitoring mass spectrometry imaging and silver-109 nanoparticle-based surface assisted laser desorption/ionization mass spectrometry imaging. Anal Chem. 2020;92:4251–8.
Article
Google Scholar
Nizioł J, Copié V, Tripet BP, et al. Metabolomic and elemental profiling of human tissue in kidney cancer. Metabolomics. 2021;17:30.
Article
Google Scholar
Jorge S, Pereira K, López-Fernández H, et al. Ultrasonic-assisted extraction and digestion of proteins from solid biopsies followed by peptide sequential extraction hyphenated to MALDI-based profiling holds the promise of distinguishing renal oncocytoma from chromophobe renal cell carcinoma. Talanta. 2020;206: 120180.
Article
CAS
Google Scholar
Atacan K, Cakiroglu B, Ozacar M. Efficient protein digestion using immobilized trypsin onto tannin modified Fe3O4 magnetic nanoparticles. Colloids Surf B Biointerfaces. 2017;156:9–18.
Article
CAS
Google Scholar
Hu D, Sheng Z, Fang S, et al. Folate receptor-targeting gold nanoclusters as fluorescence enzyme mimetic nanoprobes for tumor molecular colocalization diagnosis. Theranostics. 2014;4:142–53.
Article
CAS
Google Scholar
Zhang X, Liu R, Yuan Q, et al. The precise diagnosis of cancer invasion/metastasis via 2D laser ablation mass mapping of metalloproteinase in primary cancer tissue. ACS Nano. 2018;12:11139–51.
Article
CAS
Google Scholar
Chen C, Ridzon DA, Broomer AJ, et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res. 2005;33: e179.
Article
Google Scholar
Li W, Ruan K. MicroRNA detection by microarray. Anal Bioanal Chem. 2009;394:1117–24.
Article
CAS
Google Scholar
von Brandenstein M, Pandarakalam JJ, Kroon L, et al. MicroRNA 15a, inversely correlated to PKCalpha, is a potential marker to differentiate between benign and malignant renal tumors in biopsy and urine samples. Am J Pathol. 2012;180:1787–97.
Article
Google Scholar
von Brandenstein M, Herden J, Koditz B, et al. Non-invasive urine markers for the differentiation between RCCs and oncocytoma. J Clin Lab Anal. 2021;35: e23762.
Article
Google Scholar
Gessner I, Fries J, Brune V, et al. Magnetic nanoparticle-based amplification of microRNA detection in body fluids for early disease diagnosis. J Mater Chem B. 2021;9:9–22.
Article
CAS
Google Scholar
Allen SD, Bobbala S, Karabin NB, et al. On the advancement of polymeric bicontinuous nanospheres toward biomedical applications. Nanoscale Horiz. 2019;4:258–72.
Article
CAS
Google Scholar
Renner AM, Derichsweiler C, Ilyas S, et al. High efficiency capture of biomarker miRNA15a for noninvasive diagnosis of malignant kidney tumors. Biomater Sci. 2022;10:1113–22.
Article
CAS
Google Scholar
Himbert D, Zeuschner P, Ayoubian H, et al. Characterization of CD147, CA9, and CD70 as tumor-specific markers on extracellular vesicles in clear cell renal cell carcinoma. Diagnostics (Basel). 2020. https://doi.org/10.3390/diagnostics10121034.
Article
Google Scholar
Ghossein RA, Bhattacharya S, Rosai J. Molecular detection of micrometastases and circulating tumor cells in solid tumors. Clin Cancer Res. 1999;5:1950–60.
CAS
Google Scholar
Niciński K, Krajczewski J, Kudelski A, et al. Detection of circulating tumor cells in blood by shell-isolated nanoparticle - enhanced Raman spectroscopy (SHINERS) in microfluidic device. Sci Rep. 2019;9:9267.
Article
Google Scholar
Bu J, Nair A, Kubiatowicz LJ, et al. Surface engineering for efficient capture of circulating tumor cells in renal cell carcinoma: from nanoscale analysis to clinical application. Biosens Bioelectron. 2020;162: 112250.
Article
CAS
Google Scholar
Pitre-Champagnat S, Leguerney I, Bosq J, et al. Dynamic contrast-enhanced ultrasound parametric maps to evaluate intratumoral vascularization. Invest Radiol. 2015;50:212–7.
Article
Google Scholar
Unnikrishnan S, Klibanov AL. Microbubbles as ultrasound contrast agents for molecular imaging: preparation and application. AJR Am J Roentgenol. 2012;199:292–9.
Article
Google Scholar
Abou-Elkacem L, Bachawal SV, Willmann JK. Ultrasound molecular imaging: moving toward clinical translation. Eur J Radiol. 2015;84:1685–93.
Article
Google Scholar
Wang J, Qin B, Chen X, et al. Ultrasound molecular imaging of angiogenesis using vascular endothelial growth factor-conjugated microbubbles. Mol Pharm. 2017;14:781–90.
Article
Google Scholar
Uemura H, Nakagawa Y, Yoshida K, et al. MN/CA IX/G250 as a potential target for immunotherapy of renal cell carcinomas. Br J Cancer. 1999;81:741–6.
Article
CAS
Google Scholar
Yu Z, Hu M, Li Z, et al. Anti-G250 nanobody-functionalized nanobubbles targeting renal cell carcinoma cells for ultrasound molecular imaging. Nanotechnology. 2020;31: 205101.
Article
CAS
Google Scholar
Ng HL, Lu A, Lin G, et al. The potential of liposomes with carbonic anhydrase IX to deliver anticancer ingredients to cancer cells in vivo. Int J Mol Sci. 2014;16:230–55.
Article
Google Scholar
Mahon BP, Pinard MA, McKenna R. Targeting carbonic anhydrase IX activity and expression. Molecules. 2015;20:2323–48.
Article
Google Scholar
Pastorek J, Pastorekova S. Hypoxia-induced carbonic anhydrase IX as a target for cancer therapy: from biology to clinical use. Semin Cancer Biol. 2015;31:52–64.
Article
CAS
Google Scholar
Zhu L, Guo Y, Wang L, et al. Construction of ultrasonic nanobubbles carrying CAIX polypeptides to target carcinoma cells derived from various organs. J Nanobiotechnol. 2017;15:63.
Article
Google Scholar
Zhu L, Wang L, Liu Y, et al. CAIX aptamer-functionalized targeted nanobubbles for ultrasound molecular imaging of various tumors. Int J Nanomed. 2018;13:6481–95.
Article
CAS
Google Scholar
Cai WB, Yang HL, Zhang J, et al. The optimized fabrication of nanobubbles as ultrasound contrast agents for tumor imaging. Sci Rep. 2015;5:13725.
Article
Google Scholar
Yang H, Cai W, Xu L, et al. Nanobubble-affibody: novel ultrasound contrast agents for targeted molecular ultrasound imaging of tumor. Biomaterials. 2015;37:279–88.
Article
CAS
Google Scholar
Weissleder R. Molecular imaging in cancer. Science. 2006;312:1168–71.
Article
CAS
Google Scholar
Blom JH, van Poppel H, Marechal JM, et al. Radical nephrectomy with and without lymph node dissection: preliminary results of the EORTC randomized phase III protocol 30881. EORTC Genitourinary Group Eur Urol. 1999;36:570–5.
CAS
Google Scholar
Freedland SJ, Dekernion JB. Role of lymphadenectomy for patients undergoing radical nephrectomy for renal cell carcinoma. Rev Urol. 2003;5:191–5.
Google Scholar
Guimaraes AR, Tabatabei S, Dahl D, et al. Pilot study evaluating use of lymphotrophic nanoparticle-enhanced magnetic resonance imaging for assessing lymph nodes in renal cell cancer. Urology. 2008;71:708–12.
Article
Google Scholar
German SV, Navolokin NA, Kuznetsova NR, et al. Liposomes loaded with hydrophilic magnetite nanoparticles: preparation and application as contrast agents for magnetic resonance imaging. Colloids Surf B Biointerfaces. 2015;135:109–15.
Article
CAS
Google Scholar
Lu C, Li J, Xu K, et al. Fabrication of mAb G250-SPIO molecular magnetic resonance imaging nanoprobe for the specific detection of renal cell carcinoma in vitro. PLoS ONE. 2014;9: e101898.
Article
Google Scholar
Yazdian-Robati R, Bayat P, Oroojalian F, et al. Therapeutic applications of AS1411 aptamer, an update review. Int J Biol Macromol. 2020;155:1420–31.
Article
CAS
Google Scholar
Li J, Wu C, Hou P, et al. One-pot preparation of hydrophilic manganese oxide nanoparticles as T(1) nano-contrast agent for molecular magnetic resonance imaging of renal carcinoma in vitro and in vivo. Biosens Bioelectron. 2018;102:1–8.
Article
CAS
Google Scholar
Li J, You J, Wu C, et al. T(1)-T(2) molecular magnetic resonance imaging of renal carcinoma cells based on nano-contrast agents. Int J Nanomed. 2018;13:4607–25.
Article
CAS
Google Scholar
Bellin MF. MR contrast agents, the old and the new. Eur J Radiol. 2006;60:314–23.
Article
Google Scholar
Luo K, Liu G, Zhang X, et al. Functional L-lysine dendritic macromolecules as liver-imaging probes. Macromol Biosci. 2009;9:1227–36.
Article
CAS
Google Scholar
Bex A, Vermeeren L, de Windt G, et al. Feasibility of sentinel node detection in renal cell carcinoma: a pilot study. Eur J Nucl Med Mol Imaging. 2010;37:1117–23.
Article
Google Scholar
Kuusk T, De Bruijn R, Brouwer OR, et al. Lymphatic drainage from renal tumors in vivo: a prospective sentinel node study using SPECT/CT imaging. J Urol. 2018;199:1426–32.
Article
Google Scholar
Brouwer OR, Noe A, Olmos RA, et al. Lymphatic drainage from renal cell carcinoma along the thoracic duct visualized with SPECT/CT. Lymphat Res Biol. 2013;11:233–8.
Article
CAS
Google Scholar
Kuusk T, Donswijk ML, Valdes OR, et al. An analysis of SPECT/CT non-visualization of sentinel lymph nodes in renal tumors. Ejnmmi Res. 2018;8:105.
Article
Google Scholar
Cha SW, Sohn JH, Kim SH, et al. Interaction between the tumor microenvironment and resection margin in different gross types of hepatocellular carcinoma. J Gastroenterol Hepatol. 2020;35:648–53.
Article
Google Scholar
An HW, Hou D, Zheng R, et al. A near-infrared peptide probe with tumor-specific excretion-retarded effect for image-guided surgery of renal cell carcinoma. ACS Nano. 2020;14:927–36.
Article
CAS
Google Scholar
Hou DY, Wang MD, Hu XJ, et al. An activated excretion-retarded tumor imaging strategy towards metabolic organs. Bioact Mater. 2022;14:110–9.
Article
CAS
Google Scholar
Lee YT, Tan YJ, Oon CE. Molecular targeted therapy: treating cancer with specificity. Eur J Pharmacol. 2018;834:188–96.
Article
CAS
Google Scholar
Qu L, Ding J, Chen C, et al. Exosome-transmitted lncARSR promotes sunitinib resistance in renal cancer by acting as a competing endogenous RNA. Cancer Cell. 2016;29:653–68.
Article
CAS
Google Scholar
Liu J, Boonkaew B, Arora J, et al. Comparison of sorafenib-loaded poly (lactic/glycolic) acid and DPPC liposome nanoparticles in the in vitro treatment of renal cell carcinoma. J Pharm Sci. 2015;104:1187–96.
Article
CAS
Google Scholar
Kulkarni AA, Vijaykumar VE, Natarajan SK, et al. Sustained inhibition of cMET-VEGFR2 signaling using liposome-mediated delivery increases efficacy and reduces toxicity in kidney cancer. Nanomedicine Uk. 2016;12:1853–61.
Article
CAS
Google Scholar
Abshire C, Murad HY, Arora JS, et al. Focused ultrasound-triggered release of tyrosine kinase inhibitor from thermosensitive liposomes for treatment of renal cell carcinoma. J Pharm Sci. 2017;106:1355–62.
Article
CAS
Google Scholar
Alsaab HO, Sau S, Alzhrani RM, et al. Tumor hypoxia directed multimodal nanotherapy for overcoming drug resistance in renal cell carcinoma and reprogramming macrophages. Biomaterials. 2018;183:280–94.
Article
CAS
Google Scholar
Yongvongsoontorn N, Chung JE, Gao SJ, et al. Carrier-enhanced anticancer efficacy of sunitinib-loaded green tea-based micellar nanocomplex beyond tumor-targeted delivery. ACS Nano. 2019;13:7591–602.
Article
CAS
Google Scholar
Fang J, Nakamura H, Maeda H. The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev. 2011;63:136–51.
Article
CAS
Google Scholar
Kibria G, Hatakeyama H, Sato Y, et al. Anti-tumor effect via passive anti-angiogenesis of PEGylated liposomes encapsulating doxorubicin in drug resistant tumors. Int J Pharm. 2016;509:178–87.
Article
CAS
Google Scholar
Murase Y, Asai T, Katanasaka Y, et al. A novel DDS strategy, “dual-targeting”, and its application for antineovascular therapy. Cancer Lett. 2010;287:165–71.
Article
CAS
Google Scholar
Takara K, Hatakeyama H, Kibria G, et al. Size-controlled, dual-ligand modified liposomes that target the tumor vasculature show promise for use in drug-resistant cancer therapy. J Control Release. 2012;162:225–32.
Article
CAS
Google Scholar
Kibria G, Hatakeyama H, Ohga N, et al. The effect of liposomal size on the targeted delivery of doxorubicin to Integrin αvβ3-expressing tumor endothelial cells. Biomaterials. 2013;34:5617–27.
Article
CAS
Google Scholar
Chen L, Wang Z, Xu Q, et al. The failure of DAC to induce OCT2 expression and its remission by hemoglobin-based nanocarriers under hypoxia in renal cell carcinoma. Theranostics. 2020;10:3562–78.
Article
CAS
Google Scholar
Jeena MT, Palanikumar L, Go EM, et al. Mitochondria localization induced self-assembly of peptide amphiphiles for cellular dysfunction. Nat Commun. 2017;8:26.
Article
CAS
Google Scholar
Lang Y, Tian X, Dong HY, et al. Black phosphorus quantum dots enhance the radiosensitivity of human renal cell carcinoma cells through inhibition of DNA-PKcs kinase. Cells-Basel. 2022. https://doi.org/10.3390/cells11101651.
Article
Google Scholar
Oliveira H, Thevenot J, Garanger E, et al. Nano-encapsulation of plitidepsin: in vivo pharmacokinetics, biodistribution, and efficacy in a renal xenograft tumor model. Pharm Res. 2014;31:983–91.
Article
CAS
Google Scholar
Kavi RR, Hussein MZ, Fakurazi S, et al. Increased ROS scavenging and antioxidant efficiency of chlorogenic acid compound delivered via a chitosan nanoparticulate system for efficient in vitro visualization and accumulation in human renal adenocarcinoma cells. Int J Mol Sci. 2019. https://doi.org/10.3390/ijms20194667.
Article
Google Scholar
Ravichandran S, Radhakrishnan J. Anticancer efficacy of lupeol incorporated electrospun polycaprolactone/gelatin nanocomposite nanofibrous mats. Nanotechnology. 2022. https://doi.org/10.1088/1361-6528/ac667b.
Article
Google Scholar
Liu R, Pei Q, Shou T, et al. Apoptotic effect of green synthesized gold nanoparticles from Curcuma wenyujin extract against human renal cell carcinoma A498 cells. Int J Nanomed. 2019;14:4091–103.
Article
CAS
Google Scholar
Jiang H, Wang R, Zhou F, et al. Preparation, physicochemical characterization, and cytotoxicity of selenium nanoparticles stabilized by Oudemansiella raphanipies polysaccharide. Int J Biol Macromol. 2022;211:35–46.
Article
CAS
Google Scholar
Takke A, Shende P. Magnetic-core-based silibinin nanopolymeric carriers for the treatment of renal cell cancer. Life Sci. 2021;275: 119377.
Article
CAS
Google Scholar
Beik J, Abed Z, Ghoreishi FS, et al. Nanotechnology in hyperthermia cancer therapy: from fundamental principles to advanced applications. J Control Release. 2016;235:205–21.
Article
CAS
Google Scholar
Yang C, Zhu Y, Li D, et al. Red phosphorus decorated TiO(2) nanorod mediated photodynamic and photothermal therapy for renal cell carcinoma. Small. 2021;17: e2101837.
Article
Google Scholar
Cai B, Hou M, Zhang S, et al. Dual targeting of endoplasmic reticulum by redox-deubiquitination regulation for cancer therapy. Int J Nanomedicine. 2021;16:5193–209.
Article
Google Scholar
Chen J, Ren F, Cao W, et al. Photothermal therapy enhance the anti-mitochondrial metabolism effect of lonidamine to renal cell carcinoma in homologous-targeted nanosystem. Nanomedicine-Uk. 2021;34: 102370.
Article
CAS
Google Scholar
Kannadorai RK, Chiew G, Luo KQ, et al. Dual functions of gold nanorods as photothermal agent and autofluorescence enhancer to track cell death during plasmonic photothermal therapy. Cancer Lett. 2015;357:152–9.
Article
CAS
Google Scholar
Callaghan C, Peralta D, Liu J, et al. Combined treatment of tyrosine kinase inhibitor-labeled gold nanorod encapsulated albumin with laser thermal ablation in a renal cell carcinoma model. J Pharm Sci. 2016;105:284–92.
Article
CAS
Google Scholar
Liu J, Abshire C, Carry C, et al. Nanotechnology combined therapy: tyrosine kinase-bound gold nanorod and laser thermal ablation produce a synergistic higher treatment response of renal cell carcinoma in a murine model. BJU Int. 2017;119:342–8.
Article
CAS
Google Scholar
Zhang Y, Zhu C, Zhang Z, et al. Oxidation triggered formation of polydopamine-modified carboxymethyl cellulose hydrogel for anti-recurrence of tumor. Colloids Surf B Biointerfaces. 2021;207: 112025.
Article
CAS
Google Scholar
Cheng Y, Zheng X, Zhang L, et al. Enhanced photothermal and chemotherapy of pancreatic tumors by degrading the extracellular matrix. Colloids Surf B Biointerfaces. 2023;221: 113010.
Article
CAS
Google Scholar
Wirth T, Parker N, Yla-Herttuala S. History of gene therapy. Gene. 2013;525:162–9.
Article
CAS
Google Scholar
Xu Z, Shen G, Xia X, et al. Comparisons of three polyethyleneimine-derived nanoparticles as a gene therapy delivery system for renal cell carcinoma. J Transl Med. 2011;9:46.
Article
Google Scholar
Akita H, Ishiba R, Togashi R, et al. A neutral lipid envelope-type nanoparticle composed of a pH-activated and vitamin E-scaffold lipid-like material as a platform for a gene carrier targeting renal cell carcinoma. J Control Release. 2015;200:97–105.
Article
CAS
Google Scholar
Chai D, Liu N, Li H, et al. H1/pAIM2 nanoparticles exert anti-tumour effects that is associated with the inflammasome activation in renal carcinoma. J Cell Mol Med. 2018;22:5670–81.
Article
CAS
Google Scholar
Gao X, Jiang P, Zhang Q, et al. Peglated-H1/pHGFK1 nanoparticles enhance anti-tumor effects of sorafenib by inhibition of drug-induced autophagy and stemness in renal cell carcinoma. J Exp Clin Cancer Res. 2019;38:362.
Article
Google Scholar
Tabernero J, Shapiro GI, LoRusso PM, et al. First-in-humans trial of an RNA interference therapeutic targeting VEGF and KSP in cancer patients with liver involvement. Cancer Discov. 2013;3:406–17.
Article
CAS
Google Scholar
Sakurai Y, Hatakeyama H, Sato Y, et al. Gene silencing via RNAi and siRNA quantification in tumor tissue using MEND, a liposomal siRNA delivery system. Mol Therapy. 2013;21:1195–203.
Article
CAS
Google Scholar
Sakurai Y, Hatakeyama H, Akita H, et al. Improvement of doxorubicin efficacy using liposomal anti-polo-like kinase 1 siRNA in human renal cell carcinomas. Mol Pharm. 2014;11:2713–9.
Article
CAS
Google Scholar
Sakurai Y, Hatakeyama H, Sato Y, et al. RNAi-mediated gene knockdown and anti-angiogenic therapy of RCCs using a cyclic RGD-modified liposomal-siRNA system. J Control Release. 2014;173:110–8.
Article
CAS
Google Scholar
Fujii H, Shin-Ya M, Takeda S, et al. Cycloamylose-nanogel drug delivery system-mediated intratumor silencing of the vascular endothelial growth factor regulates neovascularization in tumor microenvironment. Cancer Sci. 2014;105:1616–25.
Article
CAS
Google Scholar
Nishimura T, Yamada A, Umezaki K, et al. Self-assembled polypeptide nanogels with enzymatically transformable surface as a small interfering RNA delivery platform. Biomacromol. 2017;18:3913–23.
Article
CAS
Google Scholar
Neuberg P, Hamaidi I, Danilin S, et al. Polydiacetylenic nanofibers as new siRNA vehicles for in vitro and in vivo delivery. Nanoscale. 2018;10:1587–90.
Article
CAS
Google Scholar
Racaniello GF, Laquintana V, Vergnaud J, et al. Development of purified glycogen derivatives as siRNA nanovectors. Int J Pharm. 2021;608: 121128.
Article
CAS
Google Scholar
Takai T, Tsujino T, Yoshikawa Y, et al. Synthetic miR-143 exhibited an anti-cancer effect via the downregulation of K-RAS networks of renal cell cancer cells in vitro and in vivo. Mol Ther. 2019;27:1017–27.
Article
CAS
Google Scholar
Schumacher T, Bunse L, Pusch S, et al. A vaccine targeting mutant IDH1 induces antitumour immunity. Nature. 2014;512:324–7.
Article
CAS
Google Scholar
Sun Z, Liu B, Ruan X, et al. An enhanced immune response against G250, induced by a heterologous DNA primeprotein boost vaccination, using polyethyleneimine as a DNA vaccine adjuvant. Mol Med Rep. 2014;10:2657–62.
Article
CAS
Google Scholar
Chai D, Shan H, Wang G, et al. Combining DNA vaccine and AIM2 in H1 nanoparticles exert anti-renal carcinoma effects via enhancing tumor-specific multi-functional CD8(+) T-cell responses. Mol Cancer Ther. 2019;18:323–34.
Article
CAS
Google Scholar
Chai D, Zhang Z, Jiang N, et al. Co-immunization with L-Myc enhances CD8(+) or CD103(+) DCs mediated tumor-specific multi-functional CD8(+) T cell responses. Cancer Sci. 2021;112:3469–83.
Article
CAS
Google Scholar
Sun H, Li J, Hu W, et al. Co-immunizing with HMGB1 enhances anti-tumor immunity of B7H3 vaccine in renal carcinoma. Mol Immunol. 2021;139:184–92.
Article
CAS
Google Scholar
He X, Zhou S, Dolan M, et al. Immunization with short peptide particles reveals a functional CD8(+) T-cell neoepitope in a murine renal carcinoma model. J Immunother Cancer. 2021. https://doi.org/10.1136/jitc-2021-003101.
Article
Google Scholar
Zhang D, Qi GB, Zhao YX, et al. In situ formation of nanofibers from purpurin18-peptide conjugates and the assembly induced retention effect in tumor sites. Adv Mater. 2015;27:6125–30.
Article
CAS
Google Scholar
Li J, Wang J, Sun D, et al. Aptamer-directed specific drug delivery and magnetic resonance imaging of renal carcinoma cells in vitro and in vivo. J Biomed Nanotechnol. 2016;12:1604–16.
Article
CAS
Google Scholar
Yu Z, Wang Y, Xu D, et al. G250 antigen-targeting drug-loaded nanobubbles combined with ultrasound targeted nanobubble destruction: a potential novel treatment for renal cell carcinoma. Int J Nanomed. 2020;15:81–95.
Article
CAS
Google Scholar